Recent Activity

Loading...

LQDA

Liquidia Corporation · NASDAQ

Performance

+1.84%

1W

-6.41%

1M

-12.89%

3M

+101.43%

6M

+5.65%

YTD

+62.74%

1Y

Profile

Liquidia Corporation, a biopharmaceutical company, develops, manufactures, and commercializes various products for unmet patient needs in the United States. Its product candidates include YUTREPIA, an inhaled dry powder formulation of treprostinil for the treatment of pulmonary arterial hypertension. The company distributes generic treprostinil injection in the United States. Liquidia Corporation was founded in 2004 and is headquartered in Morrisville, North Carolina.

Investment Analysis Report: LQDA

Overview

In this investment analysis report, we will delve into the financial performance and health of LQDA, a pharmaceutical company operating in the Health Technology sector. We will analyze the company's financial statements, including the balance sheets, income statements, and cash flow statements, to gain i...

See more ...

Technical Analysis of LQDA 2024-05-10

Overview:

In analyzing the technical indicators for LQDA over the last 5 days, we will delve into the trend, momentum, volatility, and volume indicators to provide a comprehensive outlook on the possible stock price movement in the coming days. By examining these key aspects, we aim to offer valuable insights and predictions for potential invest...

See more ...

Recent News & Updates